| Literature DB >> 11756042 |
C H Sibley1, J E Hyde, P F Sims, C V Plowe, J G Kublin, E K Mberu, A F Cowman, P A Winstanley, W M Watkins, A M Nzila.
Abstract
Chemotherapy remains the only practicable tool to control falciparum malaria in sub-Saharan Africa, where >90% of the world's burden of malaria mortality and morbidity occurs. Resistance is rapidly eroding the efficacy of chloroquine, and the combination pyrimethamine-sulfadoxine is the most commonly chosen alternative. Resistant populations of Plasmodium falciparum were selected extremely rapidly in Southeast Asia and South America. If this happens in sub-Saharan Africa, it will be a public health disaster because no inexpensive alternative is currently available. This article reviews the molecular mechanisms of this resistance and discusses how to extend the therapeutic life of antifolate drugs.Entities:
Mesh：
Substances：
Year: 2001 PMID： 11756042 DOI： 10.1016/s1471-4922(01)02085-2
Source DB: PubMed Journal: Trends Parasitol ISSN： 1471-4922